ASX - By Stock
|
OPT |
Re:
Ann: Change of Director's Interest Notice - MS
|
|
yehudi
|
8 |
5.1K |
7 |
30/03/19 |
30/03/19 |
ASX - By Stock
|
8
|
5.1K
|
7
|
|
ASX - By Stock
|
OPT |
Re:
Ann: Opthea Ph2b Trial Advances With 2nd Positive Safety Review
|
|
yehudi
|
2 |
2.7K |
7 |
15/03/19 |
15/03/19 |
ASX - By Stock
|
2
|
2.7K
|
7
|
|
ASX - By Stock
|
OPT |
Re:
Ann: S&P DJI Announces March 2019 Quarterly Rebalance
|
|
yehudi
|
3 |
3.6K |
2 |
09/03/19 |
09/03/19 |
ASX - By Stock
|
3
|
3.6K
|
2
|
|
ASX - By Stock
|
OPT |
Re:
Ann: Opthea Granted Japanese Patent Covering OPT-302
|
|
yehudi
|
7 |
3.5K |
2 |
20/02/19 |
20/02/19 |
ASX - By Stock
|
7
|
3.5K
|
2
|
|
ASX - By Stock
|
OPT |
Re:
Ann: Opthea Granted Japanese Patent Covering OPT-302
|
|
yehudi
|
7 |
3.5K |
1 |
20/02/19 |
20/02/19 |
ASX - By Stock
|
7
|
3.5K
|
1
|
|
ASX - By Stock
|
OPT |
Re:
Ann: Opthea Initiates OPT-302 Diabetic Macular Edema Trial
|
|
yehudi
|
52 |
27K |
4 |
18/01/19 |
18/01/19 |
ASX - By Stock
|
52
|
27K
|
4
|
|
ASX - By Stock
|
OPT |
Re:
Ann: Opthea Initiates OPT-302 Diabetic Macular Edema Trial
|
|
yehudi
|
52 |
27K |
0 |
18/01/19 |
18/01/19 |
ASX - By Stock
|
52
|
27K
|
0
|
|
ASX - By Stock
|
OPT |
Re:
Ann: Becoming a substantial holder
|
|
yehudi
|
7 |
4.7K |
5 |
30/12/18 |
30/12/18 |
ASX - By Stock
|
7
|
4.7K
|
5
|
|
ASX - By Stock
|
OPT |
Re:
Ann: Becoming a substantial holder
|
|
yehudi
|
7 |
4.7K |
5 |
24/12/18 |
24/12/18 |
ASX - By Stock
|
7
|
4.7K
|
5
|
|
ASX - By Stock
|
OPT |
Re:
Ann: Becoming a substantial holder
|
|
yehudi
|
7 |
4.7K |
4 |
11/12/18 |
11/12/18 |
ASX - By Stock
|
7
|
4.7K
|
4
|
|
ASX - By Stock
|
OPT |
Re:
Ann: Opthea confirms final patient enrolment in Ph2b wAMD trial
|
|
yehudi
|
2 |
1.2K |
0 |
26/11/18 |
26/11/18 |
ASX - By Stock
|
2
|
1.2K
|
0
|
|
ASX - By Stock
|
OPT |
Re:
Ann: Opthea Phase 2b wAMD trial fully recruited ahead of schedule
|
|
yehudi
|
3 |
2.7K |
4 |
15/11/18 |
15/11/18 |
ASX - By Stock
|
3
|
2.7K
|
4
|
|
ASX - By Stock
|
OPT |
Re:
Ann: Opthea Phase 2b wAMD trial fully recruited ahead of schedule
|
|
yehudi
|
3 |
2.7K |
1 |
14/11/18 |
14/11/18 |
ASX - By Stock
|
3
|
2.7K
|
1
|
|
ASX - By Stock
|
OPT |
Re:
Ann: Opthea Reports Positive Data from Ph1b DME Study of OPT-302
|
|
yehudi
|
7 |
1.9K |
2 |
08/11/18 |
08/11/18 |
ASX - By Stock
|
7
|
1.9K
|
2
|
|
ASX - By Stock
|
OPT |
Re:
Ann: Opthea Reports Positive Data from Ph1b DME Study of OPT-302
|
|
yehudi
|
7 |
1.9K |
2 |
08/11/18 |
08/11/18 |
ASX - By Stock
|
7
|
1.9K
|
2
|
|
ASX - By Stock
|
OPT |
Re:
Ann: Opthea Reports Positive Data from Ph1b DME Study of OPT-302
|
|
yehudi
|
7 |
1.9K |
2 |
08/11/18 |
08/11/18 |
ASX - By Stock
|
7
|
1.9K
|
2
|
|
ASX - By Stock
|
OPT |
Re:
Ann: Opthea Reports Positive Data from Ph1b DME Study of OPT-302
|
|
yehudi
|
7 |
1.9K |
3 |
30/10/18 |
30/10/18 |
ASX - By Stock
|
7
|
1.9K
|
3
|
|
ASX - By Stock
|
OPT |
Re:
Price action
|
|
yehudi
|
7 |
2.6K |
2 |
06/10/18 |
06/10/18 |
ASX - By Stock
|
7
|
2.6K
|
2
|
|
ASX - By Stock
|
OPT |
Re:
Price action
|
|
yehudi
|
7 |
2.6K |
0 |
05/10/18 |
05/10/18 |
ASX - By Stock
|
7
|
2.6K
|
0
|
|
ASX - By Stock
|
OPT |
Price action
|
|
yehudi
|
7 |
2.6K |
2 |
05/10/18 |
05/10/18 |
ASX - By Stock
|
7
|
2.6K
|
2
|
|
ASX - By Stock
|
OPT |
Re:
Ann: Opthea Initiates OPT-302 Diabetic Macular Edema Trial
|
|
yehudi
|
52 |
27K |
4 |
04/06/18 |
04/06/18 |
ASX - By Stock
|
52
|
27K
|
4
|
|
ASX - By Stock
|
OPT |
Re:
Ann: Opthea Initiates OPT-302 Diabetic Macular Edema Trial
|
|
yehudi
|
52 |
27K |
1 |
30/04/18 |
30/04/18 |
ASX - By Stock
|
52
|
27K
|
1
|
|
ASX - By Stock
|
OPT |
Re:
Ann: Opthea Initiates OPT-302 Diabetic Macular Edema Trial
|
|
yehudi
|
52 |
27K |
1 |
30/04/18 |
30/04/18 |
ASX - By Stock
|
52
|
27K
|
1
|
|
ASX - By Stock
|
OPT |
Re:
Merck DME deal
|
|
yehudi
|
1 |
1.3K |
7 |
10/11/17 |
10/11/17 |
ASX - By Stock
|
1
|
1.3K
|
7
|
|
ASX - By Stock
|
OPT |
Re:
Ann: Opthea Presents Further Positive Data from OPT-302 Ph1/2A
|
|
yehudi
|
5 |
3.5K |
3 |
15/08/17 |
15/08/17 |
ASX - By Stock
|
5
|
3.5K
|
3
|
|
ASX - By Stock
|
OPT |
Re:
Ann: Opthea Reports Positive Phase 1/2A Clinical Results
|
|
yehudi
|
16 |
7.9K |
1 |
08/04/17 |
08/04/17 |
ASX - By Stock
|
16
|
7.9K
|
1
|
|
ASX - By Stock
|
OPT |
Re:
Ann: Opthea Reports Positive Phase 1/2A Clinical Results
|
|
yehudi
|
16 |
7.9K |
2 |
04/04/17 |
04/04/17 |
ASX - By Stock
|
16
|
7.9K
|
2
|
|
ASX - By Stock
|
OPT |
Re:
Ann: Opthea Reports Positive Phase 1/2A Clinical Results
|
|
yehudi
|
16 |
7.9K |
1 |
04/04/17 |
04/04/17 |
ASX - By Stock
|
16
|
7.9K
|
1
|
|
ASX - By Stock
|
OPT |
Re:
Ann: Trading Halt
|
|
yehudi
|
14 |
5.9K |
7 |
01/04/17 |
01/04/17 |
ASX - By Stock
|
14
|
5.9K
|
7
|
|
ASX - By Stock
|
OPT |
Re:
Ann: Change in substantial holding
|
|
yehudi
|
7 |
3.1K |
2 |
15/02/17 |
15/02/17 |
ASX - By Stock
|
7
|
3.1K
|
2
|
|
ASX - By Stock
|
OPT |
Re:
Ann: Change in substantial holding
|
|
yehudi
|
7 |
3.1K |
7 |
14/02/17 |
14/02/17 |
ASX - By Stock
|
7
|
3.1K
|
7
|
|
ASX - By Stock
|
OPT |
Re:
Ann: Appendix 3B
|
|
yehudi
|
5 |
2.5K |
1 |
11/02/17 |
11/02/17 |
ASX - By Stock
|
5
|
2.5K
|
1
|
|
ASX - By Stock
|
OPT |
Re:
Ann: Appendix 3B
|
|
yehudi
|
5 |
2.5K |
1 |
10/02/17 |
10/02/17 |
ASX - By Stock
|
5
|
2.5K
|
1
|
|
ASX - By Stock
|
OPT |
Re:
Ann: Appendix 3B
|
|
yehudi
|
5 |
2.5K |
1 |
07/02/17 |
07/02/17 |
ASX - By Stock
|
5
|
2.5K
|
1
|
|
ASX - By Stock
|
OPT |
Re:
SMH article
|
|
yehudi
|
16 |
6.1K |
0 |
03/02/17 |
03/02/17 |
ASX - By Stock
|
16
|
6.1K
|
0
|
|
ASX - By Stock
|
OPT |
Re:
SMH article
|
|
yehudi
|
16 |
6.1K |
2 |
02/02/17 |
02/02/17 |
ASX - By Stock
|
16
|
6.1K
|
2
|
|
ASX - By Stock
|
OPT |
Re:
SMH article
|
|
yehudi
|
16 |
6.1K |
2 |
02/02/17 |
02/02/17 |
ASX - By Stock
|
16
|
6.1K
|
2
|
|
ASX - By Stock
|
OPT |
Re:
SMH article
|
|
yehudi
|
16 |
6.1K |
4 |
25/01/17 |
25/01/17 |
ASX - By Stock
|
16
|
6.1K
|
4
|
|
ASX - By Stock
|
OPT |
Re:
really really good
|
|
yehudi
|
20 |
7.0K |
2 |
21/12/16 |
21/12/16 |
ASX - By Stock
|
20
|
7.0K
|
2
|
|
ASX - By Stock
|
OPT |
Re:
really really good
|
|
yehudi
|
20 |
7.0K |
2 |
20/12/16 |
20/12/16 |
ASX - By Stock
|
20
|
7.0K
|
2
|
|
ASX - By Stock
|
OPT |
Re:
really really good
|
|
yehudi
|
20 |
7.0K |
3 |
20/12/16 |
20/12/16 |
ASX - By Stock
|
20
|
7.0K
|
3
|
|
ASX - By Stock
|
OPT |
Re:
really really good
|
|
yehudi
|
20 |
7.0K |
2 |
12/12/16 |
12/12/16 |
ASX - By Stock
|
20
|
7.0K
|
2
|
|
ASX - By Stock
|
OPT |
Re:
Ann: Opthea to Present at Ophthalmology Innovation Summit in US-OPT.AX
|
|
yehudi
|
15 |
5.5K |
3 |
10/09/16 |
10/09/16 |
ASX - By Stock
|
15
|
5.5K
|
3
|
|
ASX - By Stock
|
OPT |
Re:
Ann: Opthea reports positive data from Phase 1 wet AMD Trial-OPT.AX
|
|
yehudi
|
13 |
4.8K |
9 |
02/08/16 |
02/08/16 |
ASX - By Stock
|
13
|
4.8K
|
9
|
|
ASX - By Stock
|
OPT |
Re:
Ann: Opthea reports positive data from Phase 1 wet AMD Trial-OPT.AX
|
|
yehudi
|
13 |
4.8K |
3 |
01/08/16 |
01/08/16 |
ASX - By Stock
|
13
|
4.8K
|
3
|
|
ASX - By Stock
|
OPT |
Re:
Ann: Opthea reports positive data from Phase 1 wet AMD Trial-OPT.AX
|
|
yehudi
|
13 |
4.8K |
0 |
01/08/16 |
01/08/16 |
ASX - By Stock
|
13
|
4.8K
|
0
|
|
ASX - By Stock
|
OPT |
Re:
Ann: Opthea reports positive data from Phase 1 wet AMD Trial-OPT.AX
|
|
yehudi
|
13 |
4.8K |
4 |
26/07/16 |
26/07/16 |
ASX - By Stock
|
13
|
4.8K
|
4
|
|
ASX - By Stock
|
OPT |
Re:
Updates on OPT - Any holders around
|
|
yehudi
|
11 |
3.9K |
2 |
14/07/16 |
14/07/16 |
ASX - By Stock
|
11
|
3.9K
|
2
|
|
ASX - By Stock
|
OPT |
Re:
Updates on OPT - Any holders around
|
|
yehudi
|
11 |
3.9K |
3 |
14/07/16 |
14/07/16 |
ASX - By Stock
|
11
|
3.9K
|
3
|
|
ASX - By Stock
|
OPT |
Re:
Updates on OPT - Any holders around
|
|
yehudi
|
11 |
3.9K |
5 |
06/07/16 |
06/07/16 |
ASX - By Stock
|
11
|
3.9K
|
5
|
|